Squarepoint Ops LLC Has $3.40 Million Stock Position in Schrodinger, Inc. $SDGR

Squarepoint Ops LLC lifted its stake in shares of Schrodinger, Inc. (NASDAQ:SDGR) by 290.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 209,123 shares of the company’s stock after purchasing an additional 155,556 shares during the quarter. Squarepoint Ops LLC’s holdings in Schrodinger were worth $3,398,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Schrodinger by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 33,055 shares of the company’s stock valued at $653,000 after buying an additional 1,412 shares in the last quarter. Cetera Investment Advisers raised its stake in Schrodinger by 75.2% during the 2nd quarter. Cetera Investment Advisers now owns 29,973 shares of the company’s stock worth $603,000 after buying an additional 12,868 shares during the period. Norges Bank bought a new position in Schrodinger in the second quarter worth approximately $311,000. Invesco Ltd. boosted its holdings in Schrodinger by 15.6% in the second quarter. Invesco Ltd. now owns 155,895 shares of the company’s stock worth $3,137,000 after acquiring an additional 21,039 shares in the last quarter. Finally, First Trust Advisors LP bought a new position in Schrodinger in the second quarter worth approximately $1,227,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Schrodinger Price Performance

NASDAQ SDGR opened at $19.02 on Friday. The company has a fifty day moving average price of $17.62 and a 200-day moving average price of $14.71. The firm has a market cap of $1.40 billion, a price-to-earnings ratio of -25.70 and a beta of 1.69. Schrodinger, Inc. has a 1 year low of $10.94 and a 1 year high of $23.02.

Schrodinger (NASDAQ:SDGR) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.49. Schrodinger had a negative net margin of 20.98% and a negative return on equity of 16.37%. The company had revenue of $58.89 million for the quarter, compared to analyst estimates of $47.19 million. During the same period last year, the firm earned ($0.65) earnings per share. The firm’s revenue was up 7.5% on a year-over-year basis. On average, research analysts anticipate that Schrodinger, Inc. will post -1.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Weiss Ratings raised Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, August 27th. UBS Group assumed coverage on Schrodinger in a research report on Friday, August 14th. They set a “neutral” rating and a $19.00 target price on the stock. Finally, Wall Street Zen upgraded Schrodinger from a “strong sell” rating to a “hold” rating in a report on Saturday, August 8th. Three research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $20.50.

Schrodinger Profile

Schrödinger, Inc develops computational software designed to accelerate drug discovery and materials science research. Its platform uses physics-based modeling, machine learning and related computational methods to help scientists analyze molecular structures, predict interactions and identify potential compounds for further development.

The company’s software products support a range of research activities, including molecular modeling, virtual screening, structure-based drug design, free-energy calculations and collaborative data management.